Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-28

FDA Approved: ESTRADIOL VALERATE — Original Application (Xiromed, LLC)

View source ↗

Summary

The FDA approved Xiromed, LLC's Estradiol Valerate as an original-application generic (ANDA 216656), authorizing its marketing for approved estrogen-replacement…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRADIOL VALERATE (Estradiol valerate)

Snippet

ORIG AP for ESTRADIOL VALERATE (ESTRADIOL VALERATE)